Daratumumab in Subcutaneous Form is Safe | Can Benefit Relapsed Light-Chain Amyloid

Daratumumab in Subcutaneous Form is Safe | Can Benefit Relapsed Light-Chain Amyloid

Annual-Meeting

1 year
71 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ray Comenzo, MD, Tufts Medical Center, explains Daratumumab in Subcutaneous Form is Safe | Can Benefit Relapsed Light-Chain Amyloid at Annual Meeting 2018
Up Next Autoplay